Scientists identify genes that may help diagnose long-term Lyme disease
November 16, 2022 -- Researchers at the Icahn School of Medicine at Mount Sinai have identified 35 genes that are particularly highly expressed in people with long-term Lyme disease. The scientists contend that these genes could potentially be used as biomarkers to diagnose patients with the condition and may lead to new therapeutic targets Read More
Parkinson's medication may reduce cisplatin chemotherapy side effects
November 16, 2022 -- An international collaboration of researchers has identified a drug approved for Parkinson's disease that could be a potential game changer for cancer patients, reducing major side effects for those receiving cisplatin chemotherapy. Read More
Large DNA insertions in CRISPR-edited cells could increase cancer risk: study
July 7, 2022 -- CRISPR-Cas9 can cause large rearrangements of DNA through retrotransposition to theoretically trigger tumor development, according to a paper published in Nature Communications. Read More
Bruker launches new assay for long COVID syndrome
July 7, 2022 -- Bruker debuted its PhenoRisk PACS RuO, a research use only nuclear magnetic resonance test for molecular phenomics research on long COVID patients’ blood samples. Read More
Cell and gene therapy sector remains strong despite challenges: ARM CEO
June 30, 2022 -- The cell and gene therapy sector is “quite strong” despite the regulatory, investment, and manufacturing challenges facing the industry, according to Janet Lambert, CEO of the Alliance for Regenerative Medicine (ARM). Lambert spoke with ScienceBoard.net about developments in the industry. Read More
Machine learning model opens door to real-time detection of cell therapy contamination
June 30, 2022 -- Researchers at the Massachusetts Institute of Technology’s Singapore site have developed a new way to detect adventitious microbial contamination in mesenchymal stromal cell cultures. By using machine learning to predict if a culture is contaminated in near real-time, the approach could enable testing to take place during the production of cell therapy products. Read More
Science In Brief
Conferences
Connect
Latest Tweets